| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/04/2006 | US20060094784 Tgf-alpha expression inhibitors |
| 05/04/2006 | US20060094783 Use of R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof |
| 05/04/2006 | US20060094782 Compositions and dosage forms for enhanced absorption |
| 05/04/2006 | US20060094781 Method of treating extracellular matrix |
| 05/04/2006 | US20060094780 Novel antibiotic compounds |
| 05/04/2006 | US20060094779 (7-beta,9abeta)-1,5-dichloro-2-hydroxygibba-1,3,4a(10a),4b-tetraen-6-one for example; variety of conditions such as hot flashes, anxiety, depression, estrogen-dependent cancers, inflammatory diseases, mild cognitive impairment, bone disorders, incontinence |
| 05/04/2006 | US20060094778 Vesicant treatment with phenyl-phenyl type vitamin d receptor modulators |
| 05/04/2006 | US20060094777 Teat disinfectant having zinc EDTA, and methods |
| 05/04/2006 | US20060094775 Remedy for corneal ulcer |
| 05/04/2006 | US20060094774 Cannabinoid crystalline derivatives and process of cannabinoid purification |
| 05/04/2006 | US20060094772 Method for detecting intracellular cholesterol |
| 05/04/2006 | US20060094771 Carvedilol pharmasolve solvate |
| 05/04/2006 | US20060094770 6-[[1-phenyl-2-(4-pyridinyl)-1H-benzimidazol-6-yl]oxy]hexanoic acid methyl ester; antiinflammatory agents; microglia activators; neurodegenerative diseases |
| 05/04/2006 | US20060094769 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 05/04/2006 | US20060094768 Thiophene derivative ppar modulators |
| 05/04/2006 | US20060094767 Antitubercular agent; antibiotic against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria; e.g. (R)-2-methyl-6-nitro-2-(4-(4-(4-trifluoromethoxyphenoxy)piperidin-1-yl)phenoxymethyl)-2,3-dihydroimidazo(2,1-b)oxazole |
| 05/04/2006 | US20060094766 Epothilone derivatives for the treatment of multiple myeloma |
| 05/04/2006 | US20060094765 Use of a sri and vitamin b6 for the treatment of neurological and mental disorders |
| 05/04/2006 | US20060094764 Cyanothiophenes, their preparation and their use in pharmaceutical compositions |
| 05/04/2006 | US20060094763 Polymorphic forms of 6-[2-(methylcarbomoyl) phenyl sulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazole |
| 05/04/2006 | US20060094762 Magnesium salt of imidazole derivative |
| 05/04/2006 | US20060094761 such as 4-{4-fluoromethyl-2-methyl-5-[(4-carbamimidoyl-benzyloxy)-methyl]-pyridin-3-yloxymethyl}-benzamidine, that inhibit the proteases of the blood and thus block platelet aggregation, used for the treatment of cardiovascular disorders |
| 05/04/2006 | US20060094760 Composition, system and method of treatment of gastrointestinal disorders with nizatidine oral solution |
| 05/04/2006 | US20060094759 1-methyl-3-ethoxymethyl-4-(3,4-dichlorophenyl)-piperidine; nervous system disorders |
| 05/04/2006 | US20060094758 N-substituted piperidine derivatives as serotonin receptor agents |
| 05/04/2006 | US20060094757 Substantially pure cilostazol and processes for making same |
| 05/04/2006 | US20060094756 combining 6-hydroxy-3,4-dihydroquinolinone and an alkali metal carbonate; removing water using molecular sieves; adding 1-cyclohexyl-5-(4-halobutyl)-tetrazole; and recovering cilostazol. |
| 05/04/2006 | US20060094755 Novel quinoline-based metal chelators as antiviral agents |
| 05/04/2006 | US20060094754 1-[4-(4-Chloro-phenyl)-2-methyl-6-trifluoromethoxy-quinolin-3-yl]-ethanone; Cyclopropyl-[4-(4-methanesulfonyl-phenyl)-2-methyl-6-morpholin-4-yl-quinolin-3-yl]-methanone; useful in the treatment of CNS disorders comprising anxiety and depression. |
| 05/04/2006 | US20060094753 Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases |
| 05/04/2006 | US20060094752 Substituted indolizines and derivatives as CNS agents |
| 05/04/2006 | US20060094751 Quinuclidine derivatives and pharmaceutical compositions containing the same |
| 05/04/2006 | US20060094750 1-(cyclopropylmethyl)-2-(2,2-dimethylpropyl)-5-(isopropylsulfonyl)-1H-benzimidazole; for treatment of condition mediated by CB2 receptors; less toxicity, good absorption, distribution, solubility, metabolic stability, less protein binding affinity other than CB2 receptor, less drug-drug interaction |
| 05/04/2006 | US20060094749 Substituted pyridoxines as anti-platelet agents |
| 05/04/2006 | US20060094748 Aryl sulfonic pyridoxines as antiplatelet agents |
| 05/04/2006 | US20060094747 Substituted carboxylic acids |
| 05/04/2006 | US20060094746 poly(ADP-ribose) polymerase (PARP) inhibitors such as 9-hydroxythieno[2,3-c]isoquin-5(4H)-one, used for treating tumor diseases, leukaemia, sarcoma, tissue damage due to ischemia and reperfusion, inflammatory disease, retinal ischemia or brain trauma |
| 05/04/2006 | US20060094745 Use of an mTOR inhibitor in treatment of uterine leiomyoma |
| 05/04/2006 | US20060094744 Pharmaceutical dosage forms of stable amorphous rapamycin like compounds |
| 05/04/2006 | US20060094743 Isoquinoline compounds and medicinal use thereof |
| 05/04/2006 | US20060094742 Prostaglandin EP4 antagonists |
| 05/04/2006 | US20060094741 Remedies for neuropathic pain and model animals of neuropathic pain |
| 05/04/2006 | US20060094740 Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 05/04/2006 | US20060094739 pharmaceutical drug for treating a fungal infection; controlling and preventing plant pathogenic microorganisms in agricultural crops |
| 05/04/2006 | US20060094738 Small molecules that replace or agonize p53 function |
| 05/04/2006 | US20060094737 Novel uracil derivatives and medicinal use thereof |
| 05/04/2006 | US20060094736 Synthesis and antimalarial activity of pyrrolo[3,2-f]quinazoline-1,3-diamine derivatives |
| 05/04/2006 | US20060094735 Compounds for cell proliferation, anticancer agents, kinesin inbiitors |
| 05/04/2006 | US20060094734 Composition and method for inducing alertness |
| 05/04/2006 | US20060094733 Purine derivatives as liver x receptor agonists |
| 05/04/2006 | US20060094732 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 05/04/2006 | US20060094731 New medicament |
| 05/04/2006 | US20060094730 Water-soluble thalidomine derivatives |
| 05/04/2006 | US20060094729 metastatic or non-metastatic prostate cancer; for inducing apoptosis |
| 05/04/2006 | US20060094728 Combination of a SRC kinase inhibitor and a BCR-ABL inhibitor for the treatment of proliferative diseases |
| 05/04/2006 | US20060094727 Inhibitors of macrophase migration inhibitory factor and methods for identifying the same |
| 05/04/2006 | US20060094726 Quinoline derivatives as nk-2 and nk-3 receptor antagonists |
| 05/04/2006 | US20060094725 N-heterocyclic derivatives as NOS inhibitors |
| 05/04/2006 | US20060094724 inhibitor of activated blood coagulation factor X; N-(5-chloropyridin-2-yl)-3- {[(trans-4-pyrrolidin-1 -ylcyclohexyl)carbonyl]aznino}furo[3,2-c]pyridine-2-carboxaxnide; disorders caused by thrombi and emboli in a mammal; decreased toxicity, and causes few side effects |
| 05/04/2006 | US20060094723 Composition comprising a pde4 inhibitor and a pde5 inhibitor |
| 05/04/2006 | US20060094722 Combination drug |
| 05/04/2006 | US20060094721 Sulfonamides as potassium channel blockers |
| 05/04/2006 | US20060094720 NK1 antagonists |
| 05/04/2006 | US20060094719 Tetralin histamine-3 receptor antagonists |
| 05/04/2006 | US20060094718 O-substituted hydroxyaryl derivatives |
| 05/04/2006 | US20060094717 Indole, azaindole and related heterocyclic ureido and thioureido piperazine derivatives |
| 05/04/2006 | US20060094716 1-Pyridin-4-yl-urea derivatives |
| 05/04/2006 | US20060094715 5-Ht4 receptor antagonists for the treatment of heart failure |
| 05/04/2006 | US20060094714 Compounds and their use to treat diabetes and related disorders |
| 05/04/2006 | US20060094713 For therapy and prophylaxis of AMPA (alpha -amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid) flux |
| 05/04/2006 | US20060094712 N-(4-{[4-(2-fluoroethyl)-1,1-dioxido-3,4-dihydro-2H-1,2,4-benzothiadiazin-7-yl]oxy}benzyl)methanesulphonamide; modulating AMPA(alpha -amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid) receptor |
| 05/04/2006 | US20060094711 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 05/04/2006 | US20060094710 Piperidine-pyridazones and phthalazones as pde4 inhibitors |
| 05/04/2006 | US20060094709 Methods for the treatment of bipolar disorder using carbamazepine |
| 05/04/2006 | US20060094708 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 05/04/2006 | US20060094707 Constrained compounds as CGRP-receptor antagonists |
| 05/04/2006 | US20060094706 e.g. 7-Biphenyl-4-yl-5-(4-chlorophenyl)pyrazole[1,5a]pyrimidine-2-carbocylic acid ethyl ester; serine/threonine and tyrosine protein kinases inhibitor; vascular endothelial and fibroblast growth factor receptor antagonist; antiproliferative, antitumor, antiinflammatory agent, viricide |
| 05/04/2006 | US20060094705 Quetiapine analogs and methods of use thereof |
| 05/04/2006 | US20060094704 Treatment of premature ejaculation |
| 05/04/2006 | US20060094703 Novel amorphous hydrate of a cephalosporin antibiotic |
| 05/04/2006 | US20060094702 5-HT4 receptor antagonists |
| 05/04/2006 | US20060094701 Respiratory system disorders; antiinflamamtory agents; side effect reduction; administering terbutaline |
| 05/04/2006 | US20060094700 Heat sterilization of a steroid in the presence of phosphate |
| 05/04/2006 | US20060094699 Combination therapy using an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and a glucocorticoid receptor agonist to minimize the side effects associated with glucocorticoid receptor agonist therapy |
| 05/04/2006 | US20060094698 Self-administered contraceptive injection of oily solution |
| 05/04/2006 | US20060094697 Methods of simultaneously treating ocular rosacea and acne rosacea |
| 05/04/2006 | US20060094696 Oestrogen derivatives as inhibitors of steroid sulphatase |
| 05/04/2006 | US20060094695 Hypoestoxides, derivatives and agonists thereof for use in the prophylaxis and treatment of obesity |
| 05/04/2006 | US20060094694 Heterocyclic compounds and thrombopoietin receptor activators |
| 05/04/2006 | US20060094693 Methods and compositions for treating glucose-associated conditions, metabolic syndrome, dyslipidemias and other conditions |
| 05/04/2006 | US20060094692 Pharmaceutical formulations of camptothecins and process for making same |
| 05/04/2006 | US20060094691 Inclusion complexes of rosiglitazone |
| 05/04/2006 | US20060094690 Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin |
| 05/04/2006 | US20060094689 Production of fungal extracellular immune stimulating compounds |
| 05/04/2006 | US20060094688 Histamine release inhibitor |
| 05/04/2006 | US20060094687 Formulations |
| 05/04/2006 | US20060094686 Use of corrinoids for application in skin diseases |
| 05/04/2006 | US20060094685 Medicinal composition for drug-induced neuropathy |
| 05/04/2006 | US20060094684 Co-administering the vector with rapamycin; antibodies that block B7-1 & 2, CD28 or CD40L; transgene encodes glucocerebrosidase, alpha-galactosidase A, beta-galactosidase, sphingomyelinase, iduronate sulfatase, alpha-glucosidase, alpha-iduronidase, Factor VIIA, Factor VIII or Factor IX. |
| 05/04/2006 | US20060094683 Immunomodulatory oligonucleotides |